Integer (ITGR) Set to Announce Earnings on Thursday

Integer (NYSE:ITGR) will post its quarterly earnings results before the market opens on Thursday, April 25th. Analysts expect Integer to post earnings of $1.12 per share for the quarter. Integer has set its FY24 guidance at $5.01-5.43 EPS.Persons interested in registering for the company’s earnings conference call can do so using this link.

Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, February 15th. The medical equipment provider reported $1.39 earnings per share for the quarter, topping analysts’ consensus estimates of $1.34 by $0.05. Integer had a net margin of 5.68% and a return on equity of 10.80%. The business had revenue of $413.15 million during the quarter, compared to the consensus estimate of $409.04 million. During the same period in the previous year, the firm posted $1.11 earnings per share. Integer’s revenue for the quarter was up 10.9% compared to the same quarter last year. On average, analysts expect Integer to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Integer Stock Up 1.1 %

Shares of NYSE:ITGR opened at $117.92 on Wednesday. The company has a market capitalization of $3.95 billion, a PE ratio of 43.84, a PEG ratio of 1.61 and a beta of 1.10. Integer has a 52 week low of $69.40 and a 52 week high of $121.53. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.71 and a current ratio of 2.80. The company has a 50 day moving average price of $112.31 and a two-hundred day moving average price of $99.32.

Analysts Set New Price Targets

Several brokerages recently commented on ITGR. KeyCorp increased their target price on shares of Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a report on Tuesday, April 9th. Bank of America raised shares of Integer from a “neutral” rating to a “buy” rating and raised their price target for the stock from $105.00 to $135.00 in a research report on Monday, April 15th. CL King assumed coverage on shares of Integer in a research note on Thursday, March 14th. They set a “buy” rating and a $137.00 price objective on the stock. Finally, Benchmark increased their price objective on shares of Integer from $105.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, March 28th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $120.50.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.